Company Financials

Madrigal Pharmaceuticals, Inc. Financials

United States dollar

business Madrigal Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NASDAQ: MDGL

Market Capitalization $13.49 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -27.12
Forward PE 243.49
Price to Sales TTM $18.21
Price to Book MRQ $21.55
Enterprise to Revenue 17.18
Enterprise to EBITDA -41.58

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -39.04%
Operating Margin -39.68%
Return on Assets TTM -15.78%
Return on Equity TTM -41.22%

Income Statement

Revenue TTM $740,640,000
Revenue per Share TTM $33.39
Quarterly Revenue Growth 362.00%
Gross Profit TTM $705,494,976
EBITDA $-306,007,008
Net Income to Common TTM $-289,124,992
Diluted EPS TTM $-12.89
Quarterly Earnings Growth YoY 362.03%

Balance Sheet

Total Cash MRQ $1,109,748,992
Total Cash per Share MRQ $48.86
Total Debt MRQ $
Total Debt to Equity MRQ 55.36
Current Ratio MRQ 3.44
Book Value per Share MRQ $27.56

Cash Flow

Operating Cash Flow TTM $-160,579,008
Levered Free Cash Flow TTM $-70,936,872

MDGL Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 22,704,303
Float Shares 12,837,403
Avg 10 Volume 293,110
Avg 30 Volume None
Shares Short 3,718,220
Short Ratio 11.73
Short % of Shares 18.91%
% Held by Insiders 7.66%
% Held by Institutions 105.00%

Stock Price Summary

Beta -1.05
Fifty Two Week Low $265.00
Fifty Two Week High $615.00
Fifty Two Week Change 45.98%
Day 50 MA $531.09
Day 200 MA $392.07

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date 2016-07-25
Ex Dividend Date
Last Split Factor
Last Split Date 2016-07-25